Caitong International Asset Management Co., LTD Kura Oncology, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 524 shares of KURA stock, worth $2,971. This represents 0.0% of its overall portfolio holdings.
Number of Shares
524
Previous 10,825
95.16%
Holding current value
$2,971
Previous $94.3 Million
96.33%
% of portfolio
0.0%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding KURA
# of Institutions
190Shares Held
79MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$44 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$42.2 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$39.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$37.3 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$28.1 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $379M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...